Generation Bio Number of Employees 2020-2023 | GBIO

Generation Bio number of employees from 2020 to 2023. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Generation Bio Annual Employee Count
2023 174
2022 150
2021 150
2020 100
2019 85
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.211B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.551B 19.84
Aspen Pharmacare (APNHY) South Africa $5.574B 0.00
BridgeBio Pharma (BBIO) United States $5.208B 0.00
Bausch Health Cos (BHC) Canada $2.868B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.042B 14.20
Supernus Pharmaceuticals (SUPN) United States $1.695B 0.00
Taysha Gene Therapies (TSHA) United States $0.481B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00